Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth N Ross

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Nature Metabolism|November 13, 2023
Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cellsSamantha J Linder, Tiziano Bernasocchi, Bárbara Martínez-Pastor, et al.
Nature|July 22, 2014
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancerSupriya K Saha, Christine A Parachoniak, Krishna S Ghanta, et al.
Nature|November 19, 2015
Corrigendum: Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancerSupriya K Saha, Christine A Parachoniak, Krishna S Ghanta, et al.
Nature Metabolism|February 23, 2021
A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinomaJee-Eun Choi, Carlos Sebastian, Christina M Ferrer, et al.
Nature Cancer|July 11, 2022
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1Nathaniel W Mabe, Min Huang, Guillermo N Dalton, et al.
Plos One|February 18, 2010
Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptorsMiguel Aste-Amézaga, Ningyan Zhang, Janet E Lineberger, et al.
Nature Communications|March 12, 2015
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancerMatthew J Niederst, Lecia V Sequist, John T Poirier, et al.
Cancer Cell|December 11, 2019
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged LeukemiaAndrei V Krivtsov, Kathryn Evans, Jayant Y Gadrey, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Nature Metabolism|November 13, 2023
Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cellsSamantha J Linder, Tiziano Bernasocchi, Bárbara Martínez-Pastor, et al.
Nature|July 22, 2014
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancerSupriya K Saha, Christine A Parachoniak, Krishna S Ghanta, et al.
Nature|November 19, 2015
Corrigendum: Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancerSupriya K Saha, Christine A Parachoniak, Krishna S Ghanta, et al.
Nature Metabolism|February 23, 2021
A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinomaJee-Eun Choi, Carlos Sebastian, Christina M Ferrer, et al.
Nature Cancer|July 11, 2022
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1Nathaniel W Mabe, Min Huang, Guillermo N Dalton, et al.
Plos One|February 18, 2010
Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptorsMiguel Aste-Amézaga, Ningyan Zhang, Janet E Lineberger, et al.
Nature Communications|March 12, 2015
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancerMatthew J Niederst, Lecia V Sequist, John T Poirier, et al.
Cancer Cell|December 11, 2019
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged LeukemiaAndrei V Krivtsov, Kathryn Evans, Jayant Y Gadrey, et al.
Pageof 4